Witt O - Search Results

1

Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma.

Müller M, Rösch L, Najafi S, Gatzweiler C, Ridinger J, Gerloff XF, Jones DTW, Baßler J, Kreth S, Stainczyk S, Frese K, Meder B, Westermann F, Milde T, Peterziel H, Witt O, Oehme I. Müller M, et al. Among authors: witt o. Cancers (Basel). 2021 Sep 5;13(17):4476. doi: 10.3390/cancers13174476. Cancers (Basel). 2021. PMID: 34503286 Free PMC article.

2

Histone deacetylase inhibitor Helminthosporium carbonum (HC)-toxin suppresses the malignant phenotype of neuroblastoma cells.

Deubzer HE, Ehemann V, Westermann F, Heinrich R, Mechtersheimer G, Kulozik AE, Schwab M, Witt O. Deubzer HE, et al. Among authors: witt o. Int J Cancer. 2008 Apr 15;122(8):1891-900. doi: 10.1002/ijc.23295. Int J Cancer. 2008. PMID: 18074352 Free article.

3

Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitro.

Deubzer HE, Ehemann V, Kulozik AE, Westermann F, Savelyeva L, Kopp-Schneider A, Riester D, Schwab M, Witt O. Deubzer HE, et al. Among authors: witt o. Cancer Lett. 2008 Jun 8;264(1):21-8. doi: 10.1016/j.canlet.2008.01.002. Epub 2008 Feb 8. Cancer Lett. 2008. PMID: 18262346

4

HKI 46F08, a novel potent histone deacetylase inhibitor, exhibits antitumoral activity against embryonic childhood cancer cells.

Wegener D, Deubzer HE, Oehme I, Milde T, Hildmann C, Schwienhorst A, Witt O. Wegener D, et al. Among authors: witt o. Anticancer Drugs. 2008 Oct;19(9):849-57. doi: 10.1097/CAD.0b013e32830efbeb. Anticancer Drugs. 2008. PMID: 18765999

5

HDAC family: What are the cancer relevant targets?

Witt O, Deubzer HE, Milde T, Oehme I. Witt O, et al. Cancer Lett. 2009 May 8;277(1):8-21. doi: 10.1016/j.canlet.2008.08.016. Epub 2008 Sep 27. Cancer Lett. 2009. PMID: 18824292 Review.

6

Stepwise accumulation of distinct genomic aberrations in a patient with progressively metastasizing ependymoma.

Milde T, Pfister S, Korshunov A, Deubzer HE, Oehme I, Ernst A, Starzinski-Powitz A, Seitz A, Lichter P, von Deimling A, Witt O. Milde T, et al. Among authors: witt o. Genes Chromosomes Cancer. 2009 Mar;48(3):229-38. doi: 10.1002/gcc.20635. Genes Chromosomes Cancer. 2009. PMID: 19025795

7

Histone deacetylase 8 in neuroblastoma tumorigenesis.

Oehme I, Deubzer HE, Wegener D, Pickert D, Linke JP, Hero B, Kopp-Schneider A, Westermann F, Ulrich SM, von Deimling A, Fischer M, Witt O. Oehme I, et al. Among authors: witt o. Clin Cancer Res. 2009 Jan 1;15(1):91-9. doi: 10.1158/1078-0432.CCR-08-0684. Clin Cancer Res. 2009. PMID: 19118036

8

Targeting histone deacetylases in neuroblastoma.

Witt O, Deubzer HE, Lodrini M, Milde T, Oehme I. Witt O, et al. Curr Pharm Des. 2009;15(4):436-47. doi: 10.2174/138161209787315774. Curr Pharm Des. 2009. PMID: 19199971 Review.

9

Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastoma.

Eckerle I, Muth D, Batzler J, Henrich KO, Lutz W, Fischer M, Witt O, Schwab M, Westermann F. Eckerle I, et al. Among authors: witt o. Cancer Lett. 2009 Nov 18;285(1):99-107. doi: 10.1016/j.canlet.2009.05.007. Epub 2009 Jun 3. Cancer Lett. 2009. PMID: 19497660

10

Targeting of HDAC8 and investigational inhibitors in neuroblastoma.

Oehme I, Deubzer HE, Lodrini M, Milde T, Witt O. Oehme I, et al. Among authors: witt o. Expert Opin Investig Drugs. 2009 Nov;18(11):1605-17. doi: 10.1517/14728220903241658. Expert Opin Investig Drugs. 2009. PMID: 19780707 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page